[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Adial Pharmaceuticals Inc WT (ADILW)

Adial Pharmaceuticals Inc WT (ADILW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder

AD04 achieved statistically significant mean reduction in heavy drinking days among pre-specified group of heavy drinkers, compared to placebo, with an...

ADILW : 0.0009 (-57.14%)
ADIL : 2.60 (-5.45%)
Adial Pharmaceuticals to Announce Topline Results of ONWARD™ Phase 3 Trial for AD04 in Patients With Alcohol Use Disorder

Company to host conference call on Wednesday, July 20, 2022, at 1 PM ET...

ADILW : 0.0009 (-57.14%)
ADIL : 2.60 (-5.45%)
Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley

CHARLOTTESVILLE, Va., June 28, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today issued the...

ADILW : 0.0009 (-57.14%)
ADIL : 2.60 (-5.45%)
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial

Expects Release of Top-Line Data in July...

ADILW : 0.0009 (-57.14%)
ADIL : 2.60 (-5.45%)
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial

Expects Release of Top-Line Data in July...

ADILW : 0.0009 (-57.14%)
ADIL : 2.60 (-5.45%)

Barchart Exclusives

Why Weakness in Dividend-Paying Costco Stock Is a Strong Buying Opportunity
Costco recently lowered prices on some of its Kirkland Signature products. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.